Abnormal expression and function of Fas ligand of lachrymal glands and peripheral blood in Sjögren's syndrome patients with enlarged exocrine glands

Clinical and Experimental Immunology

Volumn 129, Issue 1, 2002, Pages 177-182

  Tsubota, K ^a,b   Fujita, H ^a   Tadano, K ^a   Onoda, N ^c   Tsuzaka, K ^c   Takeuchi, T ^c  

^a TOKYO DENTAL COLLEGE   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Fas; Lachrymal gland; Salivary gland; T cell

Indexed keywords

ANTIBODY; DEXAMETHASONE; FAS LIGAND; FAS LIGAND ANTIBODY; PENICILLIN G; STEROID; STREPTOMYCIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SENSITIVITY; EXOCRINE GLAND; FEMALE; HUMAN; HUMAN TISSUE; HYPERTROPHY; IMMUNOBLOTTING; IMMUNOHISTOLOGY; LACRIMAL GLAND; LYMPHOCYTIC INFILTRATION; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN FUNCTION; SJOEGREN SYNDROME;

ADRENAL CORTEX HORMONES; ADULT; AGED; APOPTOSIS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CYTOTOXICITY, IMMUNOLOGIC; DRUG RESISTANCE; DRY EYE SYNDROMES; EXOCRINE GLANDS; FAS LIGAND PROTEIN; FEMALE; HUMANS; IMMUNOPHENOTYPING; LACRIMAL APPARATUS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE SUBSETS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; SJOGREN'S SYNDROME;

EID: 0036378071     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01882.x     Document Type: Article

References (31)

1. Fox PC, Speight PM. Current concepts of autoimmune exocrinopathy: immunologic mechanisms in the salivary pathology of Sjögren's syndrome. Crit Rev Oral Biol Med 1996; 7:144-58.
2. Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ. Sjögren's syndrome. A clinical, pathological and serological study of sixty-two cases. Medicine 1965; 44:187.
3. Sjögren H. Zur Kenntnis Keratoconjunctivitis sicca. Acta Ophthalmol 1933; 2:1-151.
4. Pflugfelder SC, Huang AJ, Feuer W, Chuchovski PT, Pereira IC, Tseng SC. Conjunctival cytologic features of primary Sjögren's syndrome. Ophthalmology 1990; 97:985-91.
5. Tsubota K, Xu KP, Fujihara T, Katagiri S, Takeuchi T. Decreased reflex tearing is associated with lymphocytic infiltration in lacrimal glands. J Rheumatol 1996; 23:313-20.
6. Tsubota K, Goto E, Fujita H et al. Treatment of dry eye by autologous serum application in Sjögren's syndrome. Br J Ophthalmol 1999; 83:390-5.
7. Tsubota K. Tear dynamics and dry eye. Prog Retin Eye Res 1998; 17:565-96.
8. Fujihara T, Fujita H, Tsubota K, Saito K, Tsuzaka K, Abe T, Takeuchi T. Preferential localization of CD8+alphaEB7+ T cells around acinar epithelial cells with apoptosis in patients with Sjögren's syndrome. J Immunol 1999; 163:2226-35.
9. Kong L, Ogawa N, Nakabayashi T et al. Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum 1997; 40:87-97.
10. Manganelli P, Bernardi P, Taliani U, Caminiti C. Echocardiographic findings in primary Sjögren's syndrome. Ann Rheum Dis 1997; 56:568.
11. Matsumura R, Kagami M, Tomioka H et al. Expression of ductal Fas antigen in sialoadenitis of Sjögren's syndrome. Clin Exp Rheumatol 1996; 14:309-11.
12. Matsumura R, Umemiya K, Kagami M et al. Glandular and extraglandular expression of the Fas-Fas ligand and apoptosis in patients with Sjögren's syndrome. Clin Exp Rheumatol 1998; 16:561-8.
13. Nakamura H, Koji T, Tominaga M et al. Apoptosis in labial salivary glands from Sjögren's syndrome (SS) patients: comparison with human T lymphotropic virus-I (HTLV-I) -seronegative and -seropositive SS patients. Clin Exp Immunol 1998; 114:106-12.
14. Ohlsson M, Skarstein K, Bolstad AI, Johannessen AC, Jonsson R. Fas-induced apoptosis is a rare event in Sjögren's syndrome. Laboratory Invest 2001; 81:95-105.
15. Sumida T, Matsumoto I, Murata H et al. TCR in Fas-sensitive T cells from labial salivary glands of patients with Sjögren's syndrome. J Immunol 1997; 158:1020-5.
16. Tsubota K, Fujita H, Tsuzaka K, Takeuchi T. Mikulicz's disease and Sjögren's syndrome. Invest Ophthalmol Vis Sci 2000; 41:1666-73.
17. Wu J, Wilson J, He J, Xiang L, Schur PH, Mountz JD. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest 1996; 98:1107-13.
18. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356:314-7.
19. Lynch DH, Watson ML, Alderson MR et al. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1994; 1:131-6.
20. Takahashi T, Tanaka M, Brannan CI et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994; 76:969-76.
21. Fisher GH, Rosenberg FJ, Straus SE et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995; 81:935-46.
22. Nagata S. Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model. J Hum Genet 1998; 43:2-8.
23. Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV. Sjögren's syndrome: Proposed criteria for classification. Arthritis Rheum 1986; 29:577-83.
24. Matsumoto I, Tsubota K, Satake Y et al. Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjögren's syndrome. J Clin Invest 1996; 97:1969-77.
25. Greenspan JS, Daniels TE, Talal N, Sylvester RA. The histopathology of Sjögren's syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol 1974; 37:217-29.
26. Xu KP, Katagiri S, Takeuchi T, Tsubota K. Biopsy of labial salivary glands and lacrimal glands in the diagnosis of Sjogren's syndrome. J Rheumatol 1996; 23:76-82.
27. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-54.
28. Schneider P, Bodmer JL, Holler N et al. Characterization of Fas (Apo-1, CD95)-Fas ligand interaction. J Bio Chem 1997; 272:18827-33.
29. Mikulicz J. Concerning a peculiar symmetrical disease of the lacrimal and salivary glands. M Classic 2 (Berliner Klin) Vochenschrift 1937; 759:165-86.
30. Morgan W, Castleman B. A clinicopathological study of 'Mikulicz's Disease'. Am J Pathol 1953; 29:471-503.
31. Morgan W. The probably systemic nature of Mikulicz's disease and its relation to Sjögren's syndrome. N Engl J Med 1954; 251:5-10.